INTRODUCTION
Pulmonary surfactant protein A (SP-A), one of the most abundant proteins of pulmonary surfactant, is synthesized and secreted by bronchiolar Clara cells and alveolar type-1I cells [1] [2] [3] [4] . Under denaturing and reducing conditions the relative molecular mass of SP-A is 28000-35000, depending on the degree of glycosylation [3] . A short N-terminal region of 7-10 amino acids is followued by 72 amino acids in a collagen-like sequence [5] . The remaining C-terminus, which consists of 149 amino acids, has sequence similarity with a number of Ca2+-dependent lectins such as surfactant protein D (SP-D) and the plasma proteins mannose-binding protein and conglutinin [1, 6, 7] . The native form of SP-A is assembled into a complex of approx. 18 similar subunits [8] [9] [10] resembling the structure of Clq of the complement system [8] . The function of SP-A in the alveolar space is not known with certainty, but studies in vitro have implicated SP-A to be involved in (i) the formation of tubular myelin in the presence of phospholipids, Ca2' and surfactant protein B [11] ; (ii) the adsorption of surfactant lipids to an air-liquid interface [12, 13] ; and (iii) the recycling of surfactant by type-II cells [14, 15] . Due to its lectin property of binding to mannose residues [16] and its structural similarities with Clq, conglutinin and mannose-binding proteins, which play a role in the defence system in plasma [17] [18] [19] [20] [21] , SP-A may have a similar function in the alveoli. Indeed SP-A has been reported (i) to stimulate alveolar macrophages to produce oxygen radicals [22] ; (ii) to enhance phagocytosis of serum-opsonized erythrocytes [23] , opsonized [22] and non-opsonized bacteria [24] , and viruses [25] ; and (iii) to stimulate chemotaxis [26] . However, little information is available about the structures on the outside of pathogens that SP-A can recognize. The aim of the present study J5-mutant of Escherichia coli. In contrast, it did not bind to 0 1 1 1 LPS of E. coli, suggesting that SP-A binds only to rough LPS. The binding of SP-A to LPS was not affected by mannan and heparin or by deglycosylation of the SP-A, indicating that the carbohydrate-binding domain and the carbohydrate moiety of SP-A are not involved in its interaction with LPS. We also observed saturable and concentration-dependent binding of SP-A to the live J5 mutant of whole E. coli, but not to its 01 1 mutant. In addition, Re LPS aggregated in the presence of SP-A, Ca2l and Na+. We conclude that SP-A associates with LPS via the lipid A moiety of rough LPS and may be involved in the anti-bacterial defences of the lung.
was to investigate the interaction of SP-A with lipopolysaccharide (LPS), a constituent of the outer membrane of Gram-negative bacteria. Therefore, binding studies were performed with fluorescein isothiocyanate (FITC)-labelled SP-A, various LPS mutants coupled to magnetic beads, and Gram-negative bacteria using flow cytometry. In addition, aggregation of LPS in the presence of SP-A was monitored by spectrophotometry.
MATERIAL AND METHODS Chemicals Hepes acid was from BDH Chemicals (Poole, Dorset, U.K.); FITC (isomer I), yeast mannan, n-octyl fl-D-glucopyranoside and heparin were from Sigma (St. Louis, MO, U.S.A.).
Pulmonary SP-A SP-A was isolated from bronchoalveolar lavage fluid of patients with alveolar proteinosis as previously described [16] . SP-A was dissolved in 5 mM Hepes buffer, pH 7.4, (1 mg/ml) and stored in small aliquots at -70 'C. The labelling of SP-A with FITC was performed as described elsewhere [27] and did not affect the properties of SP-A such as mannose binding [16] , self-aggregation [28] , lipid aggregation [28] , and stimulation of alveolar macrophages measured as lucigenin-dependent chemiluminescence [22] .
FITC-labelled SP-A was deglycosylated using N-glycosidase F (Boehringer 913782) as described previously [28] , except for one minor modification, 0.2 % Triton X-100 was replaced by 6 mM n-octyl /3-D-glucopyranoside. The 
LPS
LPS was isolated and analysed as described before [29] from the following strains: Salmonella minnesota strain R595 (Re-LPS), E. coli 0111: B4 (01 1-LPS) and its Rc mutant (J5-LPS). Lipid A used in this study was derived from S. minnesota R595 and was purchased from Sigma (St. Louis, MO, U.S.A.). associated fluorescence was determined as described elsewhere [31] .
Aggregation of LPS by SP-A
Re-LPS (25 ,ug/ml) was suspended in 5 mM Tris/ 150 mM NaCl buffer, pH 7.4, by sonication. To this suspension SP-A (10 ,tg/ml) was added. Subsequently, the reaction mixture was transferred to reference and sample cuvettes (final volume 1 ml). The aggregation was initiated by the addition of CaCl2 (final concentration 0.5 mM) to the sample cuvette and monitored at 37°C and 400 nm using an Aminco DW-2a spectrophotometer.
RESULTS

Binding of SP-A to Re-LPS beads
Approximately three to four times as much FITC-SP-A was bound to beads coated with Re-LPS as to control beads ( 
Coating of magnetic beads with LPS
The coating of magnetic beads with LPS was performed as described previously [29] . Briefly, magnetic beads (4 x 107 tosylactivated Dynabeads; M-450, Dynal A. S., Oslo, Norway) were incubated for 48 h at room temperature with 0.1 M sodium carbonate buffer, pH 9.5, with or without 1 mg/ml LPS dispersed by sonication. Thereafter, the beads were collected with a magnet and washed four times with Hanks balanced salt solution supplemented with BSA and 0.10% (w/v) azide (HBBS). The presence of LPS bound to the beads could be demonstrated using specific antisera such as rabbit anti-(O1 1 1-LPS) and mouse anti-(lipid A) monoclonal antibody 8-2 [30] for smooth and rough LPS respectively.
Fluorimetric binding assay
Beads (1 x 107/ml of HBBS), coated with or without LPS (control beads), were washed three times with a buffer consisting of 5 mM Hepes/50 mM NaCl, pH 7.4, supplemented with 0.1 0% (w/v) BSA (buffer B). Subsequently, the beads were incubated with a buffer consisting of 5 mM Hepes/50 mM NaCl/l % BSA, pH 7.4, to prevent aspecific binding of proteins, for 1 h at 37°C on a rotator. After washing with buffer B, the beads were suspended in buffer B supplemented with 5 mM CaC12 (incubation buffer; 1 x 106 beads/ml), unless otherwise stated. A sample of bead suspension (0.01 ml) was incubated with FITC-SP-A and incubation buffer (final reaction volume: 0.3 ml) at 37 'C. After I h the incubation was terminated by washing the beads three times with 0.4 ml of buffer B. The beads were suspended in 0.25 ml of buffer B. The bead-associated fluorescence, a measure for the amount of SP-A bound to the beads, was determined using a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, U.S.A.) as described elsewhere [29] .
To study the binding of FITC-SP-A to whole bacteria, 0.1 ml of bacteria (5 x 108/ml), either E. coli 0111 or J5, was incubated with the indicated concentrations of FITC-SP-A (adjusted to a total volume of 0.2 ml using buffer A) at 37 'C for 30 min. [27] . Neither mannan nor heparin influenced the binding of FITC-SP-A to Re-LPS beads (Figure 3a) . Also removal of the whole carbohydrate moiety of 
Aggregation of Re-LPS inducei
The interaction of SP-A wit] aggregation studies (Figure 4 observed in the absence of Si aggregation of SP-A was probably due to self-aggrega However, when SP-A and Re ions were introduced into the initiated, reaching a maximun
Binding of FITC-SP-A to live I
To assess whether SP-A ca binding studies were perform J5 or 0111 strains of E. c affinity to the J5 mutant of plateau at approx. 20 ,tg/ml, whereas no binding of SP-A to 0 11 strain of E. coli was observed (U; Figure 5 ).
DISCUSSION
This study demonstrates that SP-A binds to rough LPS in the presence of Ca2+ and Na+ (Figures 1 and 2) . The SP-A concentration required for optimal binding to Re-LPS (approx. 25 ,tg/ml) is similar to the SP-A concentration measured in bronchoalveolar lavage of humans [32] . Therefore, it is likely that enough SP-A will be present in situ to bind LPS.
___________________
Binding studies in the presence of mannan or heparin ( Figure  3a) or with deglycosylated SP-A (Figure 3b) [38] . As suggested in the present study, SP-A may bind and aggregate LPS via the lipid A moiety.
d by SP-A However, it can not be excluded that SP-A may also interact with h free LPS was also studied using the 0-antigen of those Gram-negative bacteria that are highly 4) . No aggregation of Re-LPS was enriched in mannose residues, as was shown for mannose-P-A (U; Figure 4 ) and only a little binding protein [39] . The amount of SP-A in the rat lung is observed without LPS, which is approx. 100 gg and that of SP-D 10 tg [40] . However, roughly tion of SP-A induced by Ca2+ [28] .
five to ten times less SP-D is needed to bind and aggregate Gram--LPS were added together and Ca2+ negative bacteria [38] and to stimulate alveolar macrophages reaction mixture, aggregation was [22, 41] . The localization of SP-A and SP-D in the alveoli also n after approx. 4 min (@ Figure 4) . differs. SP-A is predominantly associated with pulmonary surfactant whereas SP-D is largely present in the aqueous phase [42] . opsonization of Gram-negative bacteria for phagocytosis by alveolar macrophages, as was demonstrated earlier for herpes simplex virus [25] ; (ii) aggregation of these bacteria, thereby preventing adherence to the alveolarepithelium; and (iii) facilitating mucociliary clearance of the bacteria, as was suggested for SP-D [38] . In analogy with LPS-binding protein [43] , binding or complex formation of SP-A with 'free' LPS, released from dividing or dying Gram-negative bacteria, could also affect the LPS-induced synthesis and secretion of cytokines like tumour necrosis factor by alveolar macrophages.
In conclusion, our results demonstrating binding of SP-A to the lipid moiety of rough LPS underscore earlier suggestions [22, 23, 32] for a role of this protein in the antibacterial defences of the lung.
